Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-047694
Filing Date
2024-04-24
Accepted
2024-04-24 17:01:33
Documents
20
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A fgen-20240424.htm   iXBRL DEF 14A 2762212
2 GRAPHIC img65688969_0.jpg GRAPHIC 93078
3 GRAPHIC img65688969_1.jpg GRAPHIC 20642
4 GRAPHIC img65688969_2.jpg GRAPHIC 46348
5 GRAPHIC img65688969_3.jpg GRAPHIC 206876
6 GRAPHIC img65688969_4.jpg GRAPHIC 166755
7 GRAPHIC img65688969_5.jpg GRAPHIC 196479
8 GRAPHIC img65688969_6.jpg GRAPHIC 18633
9 GRAPHIC img65688969_7.jpg GRAPHIC 534827
10 GRAPHIC img65688969_8.jpg GRAPHIC 419813
  Complete submission text file 0000950170-24-047694.txt   7747469

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240424.xsd EX-101.SCH 38812
23 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240424_htm.xml XML 365704
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36740 | Film No.: 24871393
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)